Thermopylae Holdings Ltd. 4

What Happened

• Thermopylae Holdings Ltd., listed as a 10% owner of AbCellera Biologics, acquired 38,000 common shares on February 27, 2026. The weighted-average price reported was $3.44 per share, for a total reported value of $130,720. The transaction is coded "P" (purchase) and was an open-market or private purchase.

Key Details

• Transaction date: 2026-02-27; Filing date (Form 4): 2026-03-02 (timely filed).
• Price: weighted-average $3.44; underlying trade prices ranged $3.42–$3.45 (per footnote).
• Total reported value: $130,720.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote: the $3.44 figure is a weighted-average; Thermopylae offers to provide a breakdown of how many shares were bought at each price within the $3.42–$3.45 range upon request.

Context

• This was a straightforward purchase by a 10% institutional owner, not an executive insider trade. Purchases can be more informative than sales, but this filing alone doesn’t explain intent. No option exercises, awards, gifts, or tax-withholding events were reported in the provided details.